A Study of LY3454738 in Healthy Participants and Participants With Atopic Dermatitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The main purpose of this study is to investigate the safety, tolerability, and efficacy of the study drug known as LY3454738 in healthy participants and participants with atopic dermatitis. The study has three parts. Each participant will enroll in one part. The study will last 12 to 24 weeks, depending on part.
Epistemonikos ID: 9be0f09333cd22a83cddec1a5ba2d41c82328072
First added on: May 21, 2024